Assessing the Validity of the PAP Problems Triage Tool in Patients With PAP Treatment for Obstructive Sleep Apnea

Key facts

Sponsor

Kaiser Permanente

Principal Investigator

Dennis Hwang, MD

Kaiser Permanente

Intervention

TT(other)

Enrollment

375 target

Eligibility

18 years · All sexes

Timeline

2023 – 2023

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Carnevale syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07434050
  A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
  Hangzhou Sciwind Biosciences Co., Ltd.
• ENROLLING BY INVITATIONNCT07476313
  Validation and Usability Study of the SleepView+ Home Sleep Testing System for the Evaluation of Moderate to Severe Obstructive Sleep Apnea.
  Beacon Biosignals
• RECRUITINGPHASE3NCT07226765
  Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
  Amgen
• RECRUITINGNANCT07464262
  Telemonitoring With CPAP in Severe Obstructive Sleep Apnea in Primary Health Care
  Federal University of São Paulo
• RECRUITINGNCT06971874
  The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome
  Nanfang Hospital, Southern Medical University
• RECRUITINGNANCT06381115
  App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
  Mayo Clinic
• RECRUITINGNCT07060079
  The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease
  University College, London
• RECRUITINGNANCT06715228
  Efficacy of Shitali Respiratory Rehabilitation Program in Obstructive Sleep Apnea
  Cairo University

See all trials for Carnevale syndrome →